SYK
Stryker·NYSE
--
--(--)
--
--(--)
SYK fundamentals
Stryker (SYK) released its earnings on Jan 29, 2026: revenue was 7.17B (YoY +11.42%), beat estimates; EPS was 4.47 (YoY +11.47%), beat estimates.
Revenue / YoY
7.17B
+11.42%
EPS / YoY
4.47
+11.47%
Report date
Jan 29, 2026
SYK Earnings Call Summary for Q4,2025
- Record 2025 Performance: 10.3% organic growth, $25B+ revenue, 11% EPS expansion; 2026 guidance for 8-9.5% growth and $14.90-$15.10 EPS.
- Mako Dominance: 3,000+ installations, 67% Knee/33% Hip utilization (U.S.); Shoulder/Spine applications launching mid-2026.
- MedSurg Innovation: 12.6% Q4 growth driven by Acute Care and Surgical Technologies; SmartCare business unit (Vocera + care.ai) on track.
- Tariff Resilience: $400M 2026 impact offset by pricing, mix, and cost savings; 100+ basis points margin expansion maintained.
- Robotics Expansion: Handheld RPS launch in Q1 2026; Mako 4 upgrades generating incremental revenue.
EPS
Actual | 1.84 | 0.64 | 2.14 | 2.81 | 1.93 | 2.25 | 2.2 | 2.71 | 1.97 | 2.25 | 2.12 | 3 | 2.14 | 2.54 | 2.46 | 3.46 | 2.5 | 2.81 | 2.87 | 4.01 | 2.84 | 3.13 | 3.19 | 4.47 | ||||||||||||||||
Forecast | 1.8074 | 0.559 | 1.4089 | 2.5461 | 1.9853 | 2.1375 | 2.2765 | 2.7224 | 1.9454 | 2.2741 | 2.1989 | 2.8361 | 2.0023 | 2.3807 | 2.4347 | 3.2687 | 2.3557 | 2.7917 | 2.7723 | 3.8717 | 2.7144 | 3.0685 | 3.1331 | 4.3961 | ||||||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +1.80% | +14.49% | +51.89% | +10.36% | -2.79% | +5.26% | -3.36% | -0.46% | +1.26% | -1.06% | -3.59% | +5.78% | +6.88% | +6.69% | +1.04% | +5.85% | +6.13% | +0.66% | +3.52% | +3.57% | +4.63% | +2.00% | +1.82% | +1.68% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.59B | 2.76B | 3.74B | 4.26B | 3.95B | 4.29B | 4.16B | 4.70B | 4.28B | 4.49B | 4.48B | 5.20B | 4.78B | 5.00B | 4.91B | 5.82B | 5.24B | 5.42B | 5.49B | 6.44B | 5.87B | 6.02B | 6.06B | 7.17B |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.57B | 2.59B | 3.41B | 4.33B | 3.95B | 4.14B | 4.22B | 4.65B | 4.18B | 4.53B | 4.47B | 4.96B | 4.57B | 4.83B | 4.87B | 5.60B | 5.10B | 5.40B | 5.37B | 6.36B | 5.69B | 5.94B | 6.04B | 7.12B |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +0.46% | +6.54% | +9.58% | -1.54% | -0.01% | +3.61% | -1.50% | +1.10% | +2.16% | -0.78% | +0.27% | +4.79% | +4.65% | +3.52% | +0.90% | +3.80% | +2.71% | +0.32% | +2.26% | +1.18% | +3.07% | +1.45% | +0.21% | +0.65% |
Earnings Call
You can ask Aime
What factors drove the changes in Stryker's revenue and profit?What guidance did Stryker's management provide for the next earnings period?Did Stryker beat or miss consensus estimates last quarter?What is the market's earnings forecast for Stryker next quarter?What were the key takeaways from Stryker's earnings call?What is the revenue and EPS growth rate for Stryker year over year?What were the key takeaways from Stryker’s earnings call?What is Stryker's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
